GILD vs OVBC · P/E 18, rev $7.80B vs P/E 15, rev $23.5M
Gilead Sciences Inc (GILD) versus Ohio Valley Banc Corp (OVBC) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Ohio Valley Banc Corp (OVBC) is a banks - regional company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported OVBC revenue for 2026-06-30 was $23.5M. Net income was $2.9M. Revenue was up 4.5% from 2026-03-31 to 2026-06-30. OVBC currently screens at market cap $225.4M and trailing P/E 14.6.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. OVBC currently screens at market cap $225.4M and trailing P/E 14.6.
Not investment advice. Open the GILD and OVBC stock pages for the full models.
Not investment advice.